Transcripts
DR. ROCK:
Now, the chronic relapsing form
was first described by Joel Moake in 1982, and it
seemed kind of biblical that these forms depended
on these unusual forms of von Willebrand factor
multimers which enhanced the binding.
There still are not a very
large number of these patients in the literature,
reported in the literature. And in our
investigation of relapsing patients, we have not
found the von Willebrand factor multimers nor, in
fact, anything else to be predictive other than
a low platelet count.
